GOLDSTONE ASIA PHARM.(SZ:300434) Xin Lang Cai Jing·2025-10-10 06:55Group 1 - The stock price of Jinshi Asia Pharmaceutical increased by 2.00% on October 10, reaching 9.68 CNY per share, with a total market capitalization of 3.889 billion CNY [1] - Year-to-date, the stock price has risen by 18.32%, with a slight increase of 0.73% over the last five trading days, but a decline of 3.49% over the last 20 days and 3.39% over the last 60 days [1] - The company has seen a net inflow of 1.4607 million CNY from major funds, with significant buying and selling activity recorded [1] Group 2 - Jinshi Asia Pharmaceutical, established on July 15, 2004, and listed on April 24, 2015, is based in Chengdu, Sichuan, and Hangzhou, Zhejiang [2] - The company's main business includes the research, production, and sales of pharmaceuticals and health foods, with 82.76% of revenue coming from drug sales [2] - As of June 30, the number of shareholders increased by 14.00% to 22,800, while the average circulating shares per person decreased by 12.28% [2] Group 3 - Since its A-share listing, Jinshi Asia Pharmaceutical has distributed a total of 170 million CNY in dividends, with 71.9122 million CNY distributed over the past three years [3]